Research suggests that Cordyceps sinensis, a fungus used in Traditional Chinese Medicine, can combat idiopathic pulmonary fibrosis (IPF) in mice. A study by Sichuan International Medical Exchange and Promotion Association found that this fungus inhibits mitochondrion-mediated oxidative stress, alleviating the severe respiratory disease. IPF is a progressive lung disease leading to respiratory failure, with current treatments having significant adverse effects. Published in Wiley’s MedComm, the study showed Cordyceps sinensis reduces pulmonary inflammation and collagen deposition in mice by regulating mitochondrial oxidative phosphorylation. The research indicates potential for Cordyceps sinensis as an alternative therapy, pending further validation through in vivo and in vitro experiments.
Home » Cordyceps Sinensis: Promising Natural Therapy for Idiopathic Pulmonary Fibrosis
Cordyceps Sinensis: Promising Natural Therapy for Idiopathic Pulmonary Fibrosis
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Fasting Mimetic Supplement Shows Cardioprotective Promise
November 30, 2024
Breaking the Code: Enzyme TYK2 Offers Hope for Alzheimer’s Treatment
November 30, 2024
Sucrosomial® B12: A Breakthrough in B12 Supplementation
November 30, 2024
Harnessing Beneficial Bacteria: A Breakthrough in UTI Management
November 25, 2024
Activ’Inside’s Belight: A Natural Solution for Skin Hyperpigmentation
November 22, 2024